Press release
Influence of Covid-19 on Sexually Transmitted Diseases (STDs) Drug Market
Transparency Market Research (TMR) observes, the global sexually transmitted diseases (STDs) drug market is highly competitive due to presence of several strong players. The key players are investing on the research and development activities for developing a novel drugs in order to be a part of competition. Some of the key players in the global sexually transmitted diseases drug market includes Pfizer INC, Bayer Healthcare, Hoffmann La Roche, Eli Lilly, Bristol-Myers Squibb Co., Johnson & Johnson, AbbVie, Inc., GlaxoSmithKline Plc, Gilead Sciences, and Merck & Co., Inc.TMR anticipated the global revenue of the sexually transmitted diseases (STDs) drug is estimated at US$32,826.3 mn in 2016 and expand with a CAGR of 11.2% over the forecast period from 2017 to 2025. With this pace, the market is anticipated to attain the value of US$83,041.3 mn by the end of 2025. Among various therapy classes, antibiotics segment is expected to account for the dominant share being the most frequently prescribed products in the modern medicine. Regionally, North America is accounting for the largest share in the global sexually transmitted diseases drug market.
Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34043
Government Initiatives for Adoption of Drugs to Boost Growth
Prevalence of unprotected sex is a major reason behind the increasing prevalence of sexually transmitted diseases. In addition, changing lifestyle and having several causal sex partners is leading to increase prevalence of sexually transmitted diseases over the forecast period. The rising need for treatments of these diseases is boosting demand for effective drugs and treatments which is likely to boost growth of the global sexually transmitted diseases drugs market.
Request For Covid19 Impact Analysis – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=34043
The World Health Organization (WHO) has reported nearly 468,514 gonorrhea cases, with the rate of 145.8 cases per 100,000 people, with increase of 18.5% from 2015. Numerous governments are increasingly taking steps to reduce these cases by imposing favorable policies for adoption of sexually transmitted diseases drugs is influencing positively on the growth of the global sexually transmitted diseases drugs market. Additionally, introduction of government reforms and some improvements in healthcare facilities are fuelling growth of the global sexually transmitted diseases (STDs) drugs market.
Low Rate of Detection for Diseases due to Social Stigma to Hamper Growth
Recent technological advancements have improved the diagnosis facilities and treatments, these advancements have boosted adoption of the sexually transmitted diseases drug which is likely to fuel growth of the global sexually transmitted diseases drug market.
Buy Now @ https://www.transparencymarketresearch.com/checkout.php?rep_id=34043<ype=S
Despite of these growth prospects, low rate of screening for diseases due to social stigma coupled with late diagnosis of the disease are crimping growth of the global sexually transmitted diseases drug market. Nevertheless, rising incidence of numerous sexually transmitted infections such as syphilis, gonorrhea, chlamydia, human papilloma virus, chancroid, herpes simplex virus, vaginitis, and trichomonas vaginalis are creating growth of the global sexually transmitted diseases drug market. Additionally, high number of pipeline drugs are expected to create lucrative opportunities for growth of the global sexually transmitted diseases drug market.
This information is comprised in the new report by TMR, titled “Sexually Transmitted Diseases (STDs) Drug Market (Disease Type – Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, and HIV / AIDS; Therapy Class- Antibiotics, Antiviral / Antiretrovirals, and Vaccines) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025.”
Read our Case study at : https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
The global sexually transmitted diseases (STDs) drug market has been segmented as presented:
By Disease Type:
Chlamydia
Gonorrhea
Syphilis
Genital herpes
HPV
HIV / AIDS
By Therapy Class:
Antibiotics
Antiviral / Antiretrovirals
Vaccines
By Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
Rest of Middle East & Africa
More Trending Reports by Transparency Market Research – 1. https://www.prnewswire.com/news-releases/limitations-of-in-house-medical-research-promises-growth-for-contract-research-organization-service-market-transparency-market-research-301002598.html
2. https://www.biospace.com/article/diabetic-foot-ulcers-treatment-market-surge-in-number-of-amputations-due-to-diabetic-foot-ulcers-to-propel-the-market/
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Influence of Covid-19 on Sexually Transmitted Diseases (STDs) Drug Market here
News-ID: 2125070 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for STDs
Diagnostic Testing of STDs Market Predicted Double-Digit Growth Rate by 2028
Diagnostic Testing of STDs Market Research study which offers perceptivity of in- depth delving on major and current request size along with the expected future prospects of the request and arising trends in the request. The Diagnostic Testing of STDs Market report provides crucial information about the request, including Opinions from diligence experts, and accordingly the recent progressions and developments of the Diagnostic Testing of STDs Market.
The report contains documentary…
STDs Diagnosis Market : Industry Growth, Size, Manufacturers, Sales and Demand
ReportsnReports recently announces a latest research report titled “Global STDs Diagnosis Market 2018” which highlights the STDs Diagnosis Market size, comprehensive STDs Diagnosis Industry dynamics and high-tech updates of global STDs Diagnosis Market with respect to STDs Diagnosis Industry opportunities, threats, challenges, constraints, cost structure and current trends in the STDs Diagnosis Industry. This independent 116 Page report based on analysis over 6 Major Key Players guarantees you will remain…
Sexually Transmitted Diseases (STDs) Treatment Market Outlook and Opportunity An …
Sexually transmitted disease also known as venereal diseases is a clinical syndrome of infection, acquired and transmitted through sexual activity via body fluids such as semen, vaginal fluid or blood. Causative agent of STD are bacteria, parasites, yeast, and viruses. Symptoms of STDs includes skin rashes, warts, abdominal pain or genital ulcers. STDs are detected by physical examination or assays such as ELISA (Enzyme Linked Immunosorbent Assay), rapid plasma reagin…
Sexually Transmitted Diseases (STDs) Treatment Market Opportunity Analysis, 2018 …
Sexually transmitted disease also known as venereal diseases is a clinical syndrome of infection, acquired and transmitted through sexual activity via body fluids such as semen, vaginal fluid or blood. Causative agent of STD are bacteria, parasites, yeast, and viruses. Symptoms of STDs includes skin rashes, warts, abdominal pain or genital ulcers. STDs are detected by physical examination or assays such as ELISA (Enzyme Linked Immunosorbent Assay), rapid plasma reagin…
Global Diagnostic Testing of STDs Market to Reach US$108.5 bn by 2019, Propelled …
Transparency Market Research has published a new report on the global diagnostic testing of STDs market. As per the report, the global diagnostic testing of STDs market is expected to expand at an 8.10% CAGR during the period from 2013 to 2019. The report, titled ‘Diagnostic Testing of STDs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the global diagnostic testing of…
World conference on STDs, STIs & HIV/AIDS
"World Conference on STDs, STIs & HIV/AIDS is a leading Conference in Canada, the program will explore new scientific knowledge and provides a platform for professionals and community members to participate in a structured dialogue on the major issues. The main objective will be to share scientific discoveries and clinical care on HIV and STDs, HIV diagnosis and therapy that would comprise various methods to diagnose HIV, HIV drug discovery,…
